Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
Lung Cancer
,
Oncology
Dabrafenib Shows Promising Results in Patients with Stage IV NSCLC
Read More
Mammography Screening Rates Enhanced by Copay Elimination
Read More
Strategies to Overcome the Challenges of Personalized Medicine
Read More
Two Genetic Tests Can Prevent Overtreatment of Early Prostate Cancer
Read More
FDA Approvals
Pazopanib: First Positive Maintenance Trial in Ovarian Cancer
Read More
Causes of Hospital Readmissions of Patients with Cancer
Read More
Two Surveys Confirm Drug Shortages Are a Persistent Problem, Increasing Costs
Read More
Poor Adherence to Oral Cancer Drugs a Growing Concern
Read More
Routine Surveillance CT Costly, Unnecessary in Lymphoma in Remission
Read More
Use of High-Cost Diagnostic Tests for Lung Cancer Surveillance Rising
Read More
170
171
172
173
174
175
176
Page 173 of 244
Results 1721 - 1730 of 2434